...
首页> 外文期刊>Otology and neurotology: official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology >Re: Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis, otology & neurotology 33:1308-1314, 2012
【24h】

Re: Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis, otology & neurotology 33:1308-1314, 2012

机译:回复:第三代双膦酸盐用于治疗耳硬化症,耳病学和神经病学中的感音神经性听力丧失33:1308-1314,2012

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor: We read with interest the article entitled "Third-generation bisphosphonates for treatment of sensor-ineural hearing loss in otosclerosis." The authors should be congratulated for bringing this information to our attention. Having used the various generations of bisphosphonates in our practice for the treatment of otosclerosis for a period of 19 years, we would like to make some comments on this paper.
机译:致编辑:我们感兴趣地阅读了标题为“第三代双膦酸盐治疗耳硬化症患者的感音神经性听力损失”的文章。应该祝贺作者提请我们注意此信息。在我们的实践中使用了多代双膦酸盐治疗耳硬化症已有19年了,我们想对本文进行一些评论。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号